GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (SHSE:603259) » Definitions » Price-to-Owner-Earnings

Wuxi AppTec Co (SHSE:603259) Price-to-Owner-Earnings : 24.87 (As of Apr. 30, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Wuxi AppTec Co Price-to-Owner-Earnings?

As of today (2024-04-30), Wuxi AppTec Co's share price is ¥44.02. Wuxi AppTec Co's Owner Earnings per Share (TTM) ended in Dec. 2023 was ¥1.77. It's Price-to-Owner-Earnings for today is 24.87.


The historical rank and industry rank for Wuxi AppTec Co's Price-to-Owner-Earnings or its related term are showing as below:

SHSE:603259' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 23.79   Med: 54.91   Max: 271.1
Current: 24.82

During the past 10 years, the highest Price-to-Owner-Earnings of Wuxi AppTec Co was 271.10. The lowest was 23.79. And the median was 54.91.


SHSE:603259's Price-to-Owner-Earnings is ranked better than
50% of 68 companies
in the Medical Diagnostics & Research industry
Industry Median: 25.575 vs SHSE:603259: 24.82

As of today (2024-04-30), Wuxi AppTec Co's share price is ¥44.02. Wuxi AppTec Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ¥3.24. Therefore, Wuxi AppTec Co's PE Ratio for today is 13.59.

As of today (2024-04-30), Wuxi AppTec Co's share price is ¥44.02. Wuxi AppTec Co's EPS without NRI for the trailing twelve months (TTM) ended in was ¥3.35. Therefore, Wuxi AppTec Co's PE Ratio without NRI for today is 13.13.

During the past 10 years, Wuxi AppTec Co's highest PE Ratio without NRI was 136.67. The lowest was 12.59. And the median was 53.14.


Wuxi AppTec Co Price-to-Owner-Earnings Historical Data

The historical data trend for Wuxi AppTec Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuxi AppTec Co Price-to-Owner-Earnings Chart

Wuxi AppTec Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 143.04 47.48 41.01

Wuxi AppTec Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.48 44.81 33.59 47.04 41.01

Competitive Comparison of Wuxi AppTec Co's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, Wuxi AppTec Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuxi AppTec Co's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Wuxi AppTec Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Wuxi AppTec Co's Price-to-Owner-Earnings falls into.



Wuxi AppTec Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Wuxi AppTec Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=44.02/1.77
=24.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wuxi AppTec Co  (SHSE:603259) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Wuxi AppTec Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Wuxi AppTec Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuxi AppTec Co (SHSE:603259) Business Description

Traded in Other Exchanges
Address
288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, CHN, 200131
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services through the discovery, development, and manufacturing spectrum for small-molecule drugs, cell therapies, and gene therapies as well as providing testing services for medical devices. Its segments comprise China-based laboratory services; U.S.-based laboratory services; Clinical research and other CRO services; CDMO services; and Others. The majority of revenue gets derived from China-based laboratory services that include small molecules discovery, such as synthetic chemistry, medicinal chemistry, analytical chemistry, biology, drug metabolism and pharmacokinetics (DMPK)/absorption, distribution, metabolism, and excretion (ADME), toxicology and bioanalytical services.

Wuxi AppTec Co (SHSE:603259) Headlines

No Headlines